Themis Medicare (NSE:THEMISMED) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:THEMISMED Themis Medicare Ltd NSE:THEMISMED
73 GF Score
Price ₹124.76
GF Value ₹141.91
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Themis Medicare Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:THEMISMED
73GF Score
Themis Medicare Ltd NSE:THEMISMED
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Themis Medicare (NSE:THEMISMED) Overvalued in 2026?

Based on GuruFocus' analysis, Themis Medicare stock appears to be undervalued. The current stock price of ₹124.76 is trading 12.1% below its estimated GF Value™ of ₹141.91. GuruFocus considers Themis Medicare to be Modestly Undervalued.

Key valuation signals for NSE:THEMISMED:

  • Short Ratio:
  • GF Value™: ₹141.91 vs. price of ₹124.76 (12.1% below fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the NSE:THEMISMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Themis Medicare Business Description

Other Exchanges 530199:India
Address Swami Vivekanand Road, 11/12, Udyog Nagar Industrial Estate, Goregaon (West), Mumbai, MH, IND, 400 104
Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.
73GF Score

Get the complete analysis for NSE:THEMISMED

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹124.76
Price
₹141.91
GF Value